Sintilimab-Nimotuzumab Induction Followed by Chemoradiation-Nimotuzumab in LA-HNSCC: Single-Arm Phase II

Clinical trial NCT07310771 · NOT_YET_RECRUITING

Trial details

NCT number: NCT07310771
Sponsor: Fujian Cancer Hospital
Status: NOT_YET_RECRUITING
Phase: Phase 2
Study type: INTERVENTIONAL

Locally Advanced Head and Neck Squamous Cell Carcinoma (LA-SCCHN)

Start date: 2026-01-10
Primary completion: 2027-07-10
Enrollment: 23

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.